REVIA NALTREXONE HCI
DEAD

Serial Number

75187094

Owner

DUPONT MERCK PHARMACEUTICAL COMPANY, THE

Attorney

Karen H. Kondrad

First Use Date

Mar 12, 1995

Filing Date

Oct 24, 1996

Add to watchlist:

No watchlists yet
View on USPTO

REVIA NALTREXONE HCI Trademark

Serial Number: 75187094 • Registration: 2163346

REVIA NALTREXONE HCI is a trademark filed by DUPONT MERCK PHARMACEUTICAL COMPANY, THE on October 24, 1996. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

DUPONT MERCK PHARMACEUTICAL COMPANY, THE (62 trademarks)

DUPONT MERCK PLAZA, BUILDING 722
WILMINGTON, DE 19807

Entity Type: 02

Trademark Details

Filing Date

October 24, 1996

Registration Date

June 9, 1998

First Use Anywhere

March 12, 1995

First Use in Commerce

March 13, 1995

Published for Opposition

March 17, 1998

Cancellation Date

March 12, 2005

Goods & Services

providing information and brochures to physicians and healthcare personnel to assist in counseling patients as part of a comprehensive treatment program for alcohol dependence

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 12, 2005 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 24, 2002 TCCA
REGISTERED-PRINCIPAL REGISTER
Jun 9, 1998 R.PR
PUBLISHED FOR OPPOSITION
Mar 17, 1998 PUBO
NOTICE OF PUBLICATION
Feb 13, 1998 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 1997 CNSA
ASSIGNED TO EXAMINER
Jun 30, 1997 DOCK
ASSIGNED TO EXAMINER
Jun 30, 1997 DOCK